Actinium Pharmaceuticals, Inc. (ATNM)
Net Income Growth
505.66%
Quarterly · Period ending:
ATNM Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported505.66%period ending
Latest reported505.66%period ending
ATNM Quarterly Net Income YoY % (35.25% → 505.66%)
Year-over-year change
High-resolution chart · PNG
ATNM net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 505.6557% | |
| 65.3532% | |
| 10.7035% | |
| 55.6449% | |
| 39.4169% | |
| -83.8293% | |
| 28.6572% | |
| 12.8653% | |
| 25.2157% | |
| 21.446% | |
| 12.426% | |
| -40.1309% | |
| -95.4551% | |
| -115.1881% | |
| -32.9213% | |
| -47.5012% | |
| -54.6903% | |
| 3.5902% | |
| -25.5486% | |
| -15.9386% | |
| -8.5622% | |
| 6.1728% | |
| -38.6223% | |
| 16.0479% | |
| 7.9968% | |
| 0% | |
| 27.1767% | |
| -7.3357% | |
| -3.3724% | |
| 10.1996% | |
| -22.4095% | |
| 2.7677% | |
| 31.0604% | |
| 21.682% | |
| 22.8943% | |
| 4.1825% | |
| -6.4915% | |
| -83.1024% | |
| -2.3697% | |
| -67.2326% | |
| 11.254% | |
| -43.187% | |
| -20.5492% | |
| 35.0666% | |
| -312.3471% | |
| 81.5857% | |
| 7.7211% | |
| -327.6566% | |
| 226.2572% | |
| -2,323.6575% | |
| 29.5133% | |
| 52.822% | |
| -78.119% | |
| 24.1948% | |
| -315,049.2255% | |
| -85,614.2857% | |
| -7,741.1635% | |
| -22,594.3571% | |
| 68.9392% | |
| 63.6946% | |
| -27.3899% | |
| 51.7237% | |
| 10.2664% | |
| -151.4679% | |
| 867.1841% | |
| -56.1453% | |
| -24.7635% | |
| -15.5856% | |
| 61.2372% | |
| 50.9328% | |
| -64.1579% | |
| 47.5838% | |
| -180.6815% | |
| -2,389.1954% | |
| 44.6262% | |
| 35.2528% |